Onconic Therapeutics

Developer of therapeutics for the treatment of cancer and gastrointestinal diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2020 groups6 employees language onconic.co.kr

Registered entities

Investor mix

11 investors on record.

Investor typeCountShare
Venture capital436%
Private equity218%
Other / undisclosed545%
Coming soon